Targeting the IGF1 axis in cancer proliferation

The insulin-like growth factor-I receptor as an oncogene

(2011) Haim Werner et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells

(2009) N. Eckstein et al.   CANCER RESEARCH

Tumor Suppressor BRCA1 Is Expressed in Prostate Cancer and Controls Insulin-like Growth Factor I Receptor (IGF-IR) Gene Transcription in an Androgen Receptor-Dependent Manner

(2009) H. Schayek et al.   CLINICAL CANCER RESEARCH

The somatotropic axis and aging: Mechanisms and persistent questions about practical implications

(2009) Andrzej Bartke   EXPERIMENTAL GERONTOLOGY

AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells

(2009) P. J. Beltran et al.   MOLECULAR CANCER THERAPEUTICS

Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer

(2008) Y-F Huang et al.   BRITISH JOURNAL OF CANCER

Insulin-Like Growth Factor Axis and Oncogenic Human Papillomavirus Natural History

(2008) T. G. Harris et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial Cancer

(2008) M. J. Gunter et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Reduced Susceptibility to Two-Stage Skin Carcinogenesis in Mice with Low Circulating Insulin-Like Growth Factor I Levels

(2008) T. Moore et al.   CANCER RESEARCH

Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer

(2008) John SP Yuen et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance

(2008) Angelo et al.   Frontiers in Bioscience-Landmark

Phase I, Pharmacokinetic and Pharmacodynamic Study of the Anti–Insulinlike Growth Factor Type 1 Receptor Monoclonal Antibody CP-751,871 in Patients With Multiple Myeloma

(2008) Martha Q. Lacy et al.   JOURNAL OF CLINICAL ONCOLOGY

IGF and Insulin Receptor Signaling in Breast Cancer

(2008) Antonino Belfiore et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

IGF-1 Receptor Inhibitors in Clinical Trials—Early Lessons

(2008) S. John Weroha et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women

(2008) M. J. Gunter et al.   JNCI-Journal of the National Cancer Institute

IGF signaling defects as causes of growth failure and IUGR

(2008) Jürgen Klammt et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Similarities and differences between insulin and IGF-I: Structures, receptors, and signalling pathways

(2008) Haim Werner et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY